Global General Purpose Syringes Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Disposable Syringes and Reusable Syringes), By Application (Medical, Veterinary, Industrial, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare

RELEASE DATE Oct 2025
REPORT ID SI16222
PAGES 240
REPORT FORMAT PathSoft

Global General Purpose Syringes Market Insights Forecasts to 2035

  • The Global General Purpose Syringes Market Size Was Estimated at USD 12.0 Billion in 2024
  • The Market Size is Expected to Grow at a CAGR of around 4.61% from 2025 to 2035
  • The Worldwide General Purpose Syringes Market Size is Expected to Reach USD 19.7 Billion by 2035
  • Asia Pacific is expected to grow the fastest during the forecast period.

Get more details on this report -

Request Free Sample PDF

 

According to a research report published by Spherical Insights and Consulting, The Global General Purpose Syringes Market Size was worth around USD 12.0 Billion in 2024 and is predicted to grow to around USD 19.7 Billion by 2035 with a compound annual growth rate (CAGR) of 4.61% from 2025 and 2035. The market for General Purpose Syringes has a number of opportunities to grow due to an increasing product development for veterinary care.

 

Market Overview

The global industry of general purpose syringes focused on the production and sale of standard syringes used for injecting or withdrawing fluids, like medication, from the body or for laboratory use. General purpose syringes are typically disposable, commonly made up of polypropylene plastic, and used for a wide range of purposes. For instance, in laboratories or institutions requiring an extremely high degree of precision, microliter syringes are used for excellent dosing of tiny aliquots. Injections are one of the most common health care procedures, accounting for 16 billion injections administered every year at a global pace. They are mainly (around 90%) given in curative care, while 5% for immunization injections.

 

Innovation and market expansion are anticipated as a result of major players' growing R&D expenditures and the expanding partnerships. The quick technological advancement in prefilled syringe technology, with growing innovations in drug administration, is driving a huge surge in the global general purpose syringes market. For instance, in December 2024, Researchers at the Indian Institute of Technology (IIT) Bombay have developed a shockwave-based needle-free syringe that ensures painless and safe drug delivery.    

 

Report Coverage

This research report categorizes the General Purpose Syringes market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the General Purpose Syringes market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the General Purpose Syringes market. 

 

Global General Purpose Syringes Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 12.0 Billion
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :CAGR of 4.61%
2035 Value Projection:USD 19.7 Billion
Historical Data for:2020-2023
No. of Pages:240
Tables, Charts & Figures:140
Segments covered:By Product Type, By Application
Companies covered::Becton, Dickinson and Company (BD) Terumo Corporation Nipro Corporation Smiths Medical B. Braun Melsungen AG Cardinal Health Medtronic plc Hindustan Syringes & Medical Devices Ltd. Gerresheimer AG SCHOTT AG Retractable Technologies, Inc. Vogt Medical Vertrieb GmbH Weigao Group Jiangsu Jichun Medical Devices Co., Ltd. and Others, Key Players
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

With the growing prevalence of chronic diseases, global push towards vaccination programs. For instance, in April 2025, the IA2030 Global report 2024, it was found that nearly 4.2 million deaths were averted by vaccination against 14 diseases in 2023, falling short of the target of nearly 4.6 million deaths. An increased demand for surgical care in low and middle-income countries (LMICs) leads to higher case fatality rates, which may ultimately drive market demand. Introduction of advancements like auto-injectors & smart syringe integration for better medication adherence in chronic disease management is promoting the market growth.     

 

Restraining Factors

The General Purpose Syringes Market Size is restricted by the increased price of the syringe, hampering adoption across small hospitals and clinics in emerging economies. Furthermore, the lack of trained personnel and inadequate healthcare infrastructure is responsible for restraining market growth.

 

Market Segmentation

 

The general purpose syringes market share is classified into product type and application.  

 

  • The disposable syringes segment dominated the market in 2024 and is projected to grow at a substantial CAGR of around 5.5%-7.0% during the forecast period.

Based on the product type, the general purpose syringes market is divided into disposable syringes and reusable syringes. Among these, the disposable syringes segment dominated the market in 2024 and is projected to grow at a substantial CAGR of around 5.5%-7.0% during the forecast period. For instance, Cole-Parmer’s B-D Disposable Syringe, Non-Sterile, Luer-Lok, are latex-free disposable polypropylene syringe used for general-purpose applications, with either Luer-Lok or slip-tip connections. Further, an increasing demand for sustainable and eco-friendly disposable solutions is contributing to driving the segmental market growth.

 

  • The medical segment accounted for the largest share of over 40% in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the general purpose syringes market is divided into medical, veterinary, industrial, and others. Among these, the medical segment accounted for the largest share of over 40% in 2024 and is anticipated to grow at a significant CAGR during the forecast period. General purpose syringe, single use with plunger intended to be used for injection/withdrawal of fluids/gas form of medication to/from a medical device or the body. With an increasing prevalence of chronic diseases, the rising demand for injectable drug delivery is driving the segmental market growth.

 

Get more details on this report -

Request Free Sample PDF

 

  

Regional Segment Analysis of the General Purpose Syringes Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the general purpose syringes market over the predicted timeframe.

North America is anticipated to hold the largest share of nearly 30-40% in the general purpose syringes market over the predicted timeframe. The market ecosystem in North America is strong, due to increasing funding and investment agreements by the leading industries. For instance, in July 2025, Stevanato Group S.p.A., a global provider of drug delivery, announced that it had secured €200 million in financing from BNL BNP Paribas, Cassa Depositi e Prestiti (CDP), and Banco BPM. The market for general purpose syringes has been driven by the region's growing healthcare expenditure and government-supported immunization programs. The U.S. is leading the North America general purpose syringes market, accounting for about 70-80% share, driven by the evolution of hospital practices and inclination towards safety-engineered syringes.

 

Get more details on this report -

Request Free Sample PDF

 

Asia Pacific is expected to grow at a rapid CAGR of nearly 9.0-10.0% in the general purpose syringes market during the forecast period. The Asia Pacific area has a thriving market for general purpose syringes due to its large-scale vaccination program, along with an increased vaccination awareness. For instance, in June 2025, Gavi, the Vaccine Alliance and the Asian Development Bank signed a new cooperation agreement in support of sustainable health and immunisation financing. Additionally, the region’s increasing prevalence of chronic disorders and increasing healthcare expenditure are contributing to propel market growth. China is positioned as the dominant country in the Asia Pacific general purpose syringes market, with over 50% share, driven by 59% production volume and being the dominant global exporter.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the general purpose syringes market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Becton, Dickinson and Company (BD)
  • Terumo Corporation
  • Nipro Corporation
  • Smiths Medical
  • B. Braun Melsungen AG
  • Cardinal Health
  • Medtronic plc
  • Hindustan Syringes & Medical Devices Ltd.
  • Gerresheimer AG
  • SCHOTT AG
  • Retractable Technologies, Inc.
  • Vogt Medical Vertrieb GmbH
  • Weigao Group
  • Jiangsu Jichun Medical Devices Co., Ltd.
  • Jiangxi Sanxin Medtec Co., Ltd.
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs) 

 

Recent Development

  • In October 2025, PharmaJet, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announced that it is expanding its needle free injection portfolio with the development of a suite of proprietary, needle-free, self-injector pens.
  • In September 2025, UltiMed, Inc., the maker of the #1 vet-recommended insulin syringe, announced the launch of UltiCare VetRx General Syringes- a new line of high-performance syringes developed to meet the diverse daily injection needs of veterinary clinics.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the general purpose syringes market based on the below-mentioned segments: 

 

Global General Purpose Syringes Market, By Product Type

  • Disposable Syringes
  • Reusable Syringes

 

Global General Purpose Syringes Market, By Application   

  • Medical
  • Veterinary
  • Industrial
  • Others

 

Global General Purpose Syringes Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies